Sanofi India share news, announcements and annual reports
NSE: SANOFIBSE: 500674Pharmaceuticals & BiotechnologySmall Cap
Sanofi India Limited · Formerly Aventis Pharma · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1984 on BSE, May 2003 on NSE
Last close ₹3,204.10up ₹14.60 (0.46%)BSE ₹3,204.40
Share price at the NSE close on 30 Oct 2026. Previous close ₹3,189.50.
30 Oct: open ₹3,265.00, high ₹3,422.60, low ₹3,175.10
52-week range of traded prices to 30 Oct 2026
₹2,758.20Low, 23 Oct 2026₹4,834.00High, 30 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹7,379 Cr614th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 20.24
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 8.93
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 3.84%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 45.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 57.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Jun 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,04,44220.0% delivered
Sanofi India share news and announcements
701 announcements, routine notices left out, newest first. Page 12 of 15.
May 2013
6 May · Disclosure of Voting Pattern - Clause 35A
Apr 2013
9 Apr · Board meeting
For approving the Unaudited Financial Results for the quarter ended March 31, 2013 (which is the first quarter of the Company's financial year).
Mar 2013
5 Mar · Dividend
Final dividend for the year ended December 31, 2012 recommended by the Board of Directors, if declared at the Annual General meeting to be held on April 30, 2013, will be paid on May 06, 2013.5 Mar · Corporate action
Register of Members and Share Transfer Books of the Company will be closed from April 09, 2013 to April 30, 2013 (both days inclusive) for the purpose of [1] Annual General Meeting to be held on April 30, 2013; and [2] Payment of Final Dividend of Rs. 29 per Equity share of Rs. 10 for the financial year ended December 31, 2012, recommended by the Board of Directors, if declared at the Annual General Meeting to be held on April 30, 2013.
Feb 2013
25 Feb · Dividend
Board of Directors of the Company at its meeting held on February 25, 2013, the Board has recommended Final dividend of Rs. 29 per Equity share of Rs. 10 for the year ended December 31, 2012.14 Feb · Management
Mr. S. Umesh has resigned as Alternate Director/Wholetime Director of the Company with effect from February 01, 2013 as he is taking up a position in the Sanofi Group in France.8 Feb · Board meeting
For approving the audited Accounts for the year ended December 31, 2012 and also to consider recommendation of final Dividend for the said financial year.
Jan 2013
Oct 2012
15 Oct · Board meeting
For approving the Unaudited Financial Results for the quarter and nine months ended September 30, 2012.
Jul 2012
25 Jul · Dividend
Board of Directors of the Company at its meeting held on July 25, 2012, declared an Interim Dividend of Rs. 4 (Rupees Four Only) per Equity Share of Rs.10 for the financial year ending December 31, 2012. The Interim Dividend will be paid on August 16, 2012.25 Jul · Results
23 Jul · Corporate action
In case Interim Dividend is declared by the Board at the Board meeting to be held on July 25, 2012, the Record date for the purpose of payment of such Interim Dividend will be August 03, 2012.5 Jul · Board meeting
For (1) Approving the Unaudited Financial Results for the quarter and half year ended June 30, 2012, and (2) Considering the question of declaring an Interim Dividend for the current financial year ending December 31, 2012.5 Jul · Change in Company Name / Symbol
Members of the Exchange are hereby informed that the name of Aventis Pharma Limited shall be changed to Sanofi India Limited and the trading symbol of the Company be changed from AVENTIS to SANOFI w.e.f. July 11, 2012.
Jun 2012
27 Jun · Management
Mr. M. Dargentolle has resigned as Chief Financial Officer and Wholetime Director of the Company with effect from the close of business hours from June 30, 2012 as he is taking up a position in the R & D Division of the Sanofi Group in France.
May 2012
16 May · Company Name Change
Name of the Company has been changed from 'AVENTIS PHARMA LIMITED' to 'SANOFI INDIA LIMITED' with effect from May 11, 2012. A Fresh Certificate of incorporation consequent upon Change of Name of the Company issued by the Registrar of Companies, Maharashtra.8 May · Disclosure of Voting Pattern - Clause 35A
Apr 2012
16 Apr · Board meeting
For approving the Unaudited Financial Results for the quarter ended March 31, 2012 (which is the first quarter of the Company's financial year).
Feb 2012
9 Feb · Board meeting
For approving the audited Accounts for the year ended December 31, 2011 and also to consider recommendation of final Dividend for the said financial year.
Nov 2011
Oct 2011
31 Oct · Board meeting
For approving the Unaudited Financial Results for the quarter and nine months ended September 30, 2011.
Aug 2011
30 Aug · Management
Mr. O. Charmeil and Mr. F. X. Duhalde have resigned as Directors of the Company with effect from August 23, 2011. The Board of Directors has appointed Mr. A. Ortoli (Senior Vice President - Intercontinental of the Sanofi Group) and Mr. F. Briens (Vice President - Finance, Intercontinental of the Sanofi Group) as Directors of the Company in the casual vacancies caused by the resignations of Mr. Charmeil and Mr. Duhalde, respectively.
Jul 2011
28 Jul · Dividend
Board of Directors of the Company at its meeting held on July 28, 2011, declared an Interim Dividend of Rs. 4 (Rupees Four Only) per Equity Share of Rs.10 for the financial year ending December 31, 2011.28 Jul · Results
28 Jul · Results
Standalone Results for the quarter ended on 30-JUN-2011 as follows: Net Sales of Rs. 30280 lacs for quarter ending on 30-JUN-2011 against Rs. 27150 lacs for the quarter ending on 30-JUN-2010. Net Profit / (Loss) of Rs. 4970 lacs for the quarter ending on 30-JUN-2011 against Rs. 4240 lacs for the quarter ending on 30-JUN-2010.21 Jul · Corporate action
In case Interim Dividend is declared by the Board at the Board meeting to be held on July 28, 2011, the Record date for the purpose of payment of such Interim dividend will be August 04, 2011.14 Jul · Board meeting
For (1) Approving the Unaudited Financial Results for the quarter and half year ended June 30, 2011, and (2) Considering the question of declaring an interim dividend for the current financial year ending December 31, 2011.
May 2011
Apr 2011
26 Apr · Results
26 Apr · Results
Standalone Results for the quarter ended on 31-MAR-2011 as follows: Net Sales of Rs. 27630 lacs for quarter ending on 31-MAR-2011 against Rs. 25140 lacs for the quarter ending on 31-MAR-2010. Net Profit / (Loss) of Rs. 5060 lacs for the quarter ending on 31-MAR-2011 against Rs. 3610 lacs for the quarter ending on 31-MAR-2010.11 Apr · Management
Mr. S. C. Ghoge has resigned as Alternate Director to Mr. F.X. Duhalde and Wholetime Director with effect from the close of business hours on March 31, 2011 as he has taken premature retirement from the services of the Company.7 Apr · Board meeting
For approving the Unaudited Financial Results for the quarter ended March 31, 2011 (which is the first quarter of the Company's financial year).
Feb 2011
17 Feb · Dividend
Date from which dividend is payable is on May 02, 2011, if declared at the Annual General Meeting to be held on April 26, 2011.